Facebook
Twitter
Telegram
Report an ErrorRhythm Pharmaceuticals Financial Statements 2011-2024 | RYTM
Annual Financial Statements Rhythm Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
2.5 B | 1.35 B | 495 M | 1.31 B | 645 M | 821 M | 424 M | - | - | - | - | - | - |
Shares |
57.7 M | 52.1 M | 49.6 M | 44.1 M | 36.4 M | 31 M | 13.3 M | - | - | - | - | - | - |
Historical Prices |
43.4 | 25.9 | 9.98 | 29.7 | 23 | 26.9 | 29.1 | - | - | - | - | - | - |
Net Income |
-185 M | -181 M | -69.6 M | -134 M | -141 M | -74.1 M | -33.7 M | -25.9 M | -11.1 M | - | -21.4 M | -18.1 M | - |
Revenue |
77.4 M | 23.6 M | 3.15 M | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
9.3 M | 2.13 M | 599 K | - | - | - | - | 2.73 M | 3.16 M | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-184 M | -179 M | -170 M | -137 M | -146 M | -78.4 M | -32.4 M | -25.9 M | -10.6 M | - | - | - | - |
Interest Expense |
13.9 M | 5.2 M | 100 M | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-183 M | -178 M | -169 M | -136 M | -145 M | -78 M | -32.2 M | -25.8 M | -10.1 M | - | -21.4 M | -18.1 M | - |
Operating Expenses |
- | - | - | - | 146 M | 78.4 M | 32.4 M | - | - | - | - | - | - |
General and Administrative Expenses |
118 M | 92 M | 68.5 M | 46.1 M | 36.6 M | 28.1 M | 9.52 M | 6.31 M | 3.42 M | - | 3.43 M | 2.46 M | - |
All numbers in USD currency
Quarterly Income Statement Rhythm Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
60.1 M | 59.4 M | 57.9 M | 56.9 M | 56.7 M | 56.6 M | 51.4 M | 50.4 M | 50.3 M | 50.3 M | 50.2 M | 50.2 M | 47.6 M | 44.2 M | 44.1 M | 44.1 M | 44 M | 44 M | 34.5 M | 34.5 M | 34.4 M | 34.4 M | 34.3 M | 28 M | 27.3 M | 27.3 M | 6.4 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-141 M | - | -44.2 M | -46.7 M | -52.2 M | - | -40.9 M | -45 M | -52.8 M | - | -35.1 M | -35.4 M | 43.8 M | - | -33.8 M | -31.1 M | -34.2 M | -33 M | -36 M | -42.8 M | -29 M | -25.5 M | -17.7 M | -14.4 M | -16.5 M | -10.5 M | -10 M | -6.8 M | -6.36 M | -8.37 M | -25.9 M | -5.73 M | -5.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
26 M | - | 22.5 M | 19.2 M | 11.5 M | - | 4.28 M | 9.07 M | 1.5 M | - | 1.03 M | 274 K | 35 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
2.81 M | - | 2.41 M | 2.24 M | 1.42 M | - | 497 K | 378 K | 230 K | - | 222 K | 137 K | 4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.73 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-140 M | - | -44 M | -46.6 M | -52.5 M | - | -39.3 M | -45.1 M | -52.7 M | - | -44.2 M | -40.4 M | -34.4 M | - | -34.3 M | -31.9 M | -35.3 M | - | -37.1 M | -44.1 M | -30.5 M | - | -19.2 M | -15 M | -17 M | - | -8.29 M | -6.75 M | -6.39 M | - | -6.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
4.76 M | - | 3.15 M | 3.3 M | 3.06 M | - | 2.14 M | 46 K | -233 K | - | 100 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | -52.3 M | - | -39.1 M | -45.1 M | -52.6 M | - | -44.1 M | -40.3 M | -34.2 M | - | -33.8 M | -31.6 M | -35.1 M | - | -36.5 M | -43.7 M | -30.3 M | - | -19 M | -14.9 M | -16.9 M | - | -8.12 M | -6.65 M | -6.34 M | - | -6.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 34.3 M | 31.9 M | 35.3 M | 34.2 M | 37.1 M | 44.1 M | 30.5 M | 27.2 M | 19.2 M | 15 M | 17 M | 11 M | 8.29 M | 6.75 M | 6.39 M | 8.38 M | 6.4 M | 5.74 M | 5.39 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
34.4 M | - | 30.5 M | 30 M | 24.6 M | - | 21.9 M | 22.3 M | 21.4 M | - | 17.5 M | 15.5 M | 14.5 M | - | 11.3 M | 8.92 M | 12.8 M | - | 10.5 M | 8.84 M | 7.76 M | - | 8.54 M | 6.44 M | 4.72 M | - | 2.32 M | 1.36 M | 1.52 M | - | 982 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency